Errata

Pharmacology 2010;86:196–202 202 16 Bernatchez G, Talwar D, Parent L: Mutations in the EF-hand motif impair the inactivation of barium currents of the cardiac 1C channel. Biophys J 1998; 75: 1727–1739. 17 O’Brien PJ, Smith DE, Knechtel TJ, et al: Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 2006; 40: 153–171. 18 York M, Scudamore C, Brady S, et al: Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat. Toxicol Pathol 2007; 35: 606–617. 19 Kahn DS, Rona G, Chappel CI: Isoproterenol-induced cardiac necrosis. Ann NY Acad Sci 1969; 156: 285–293. 20 Ling S, Lewanczuk RZ, Russell AS, Ihejirika B, Jamali F: Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab. J Clin Pharmacol 2009; 49: 301–311. 21 Abernethy DR, Wainer IW, Longstreth JA, Andrawis NS: Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration. J Pharmacol Exp Ther 1993; 266: 904–911. 22 Abernethy DR, Schwartz JB: Verapamil pharmacodynamics and disposition in obese hypertensive patients. J Cardiovasc Pharmacol 1988; 11: 209–215. 23 Hanafy S, Pinsk M, Jamali F: Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease. Pediatr Nephrol 2009; 24: 815–821. 24 Renaud JF, Kazazoglou T, Schmid A, Romey G, Lazdunski M: Differentiation of receptor sites for [ 3 H]nitrendipine in chick hearts and physiological relation to the slow Ca 2+ channel and to excitation-contraction coupling. Eur J Biochem 1984; 139: 673–681. 25 Cheng X, Liao YH, Ge H, et al: Th1/Th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 2005; 25: 246–253.